Future nanomedical devices and systems will have strong potential to enable a broad range of aerospace and space applications. With further dimensional reductions in conjunction with the increased capabilities of nanoelectronics and artificial intelligence (AI), nanomedicine may facilitate the development of a wide array of advanced nanomedical diagnostic and therapeutic capabilities dedicated to the health and well being of future astronauts and space pioneers, the inhabitants of future Lunar and Mars colonies, and deep space explorers. These nanomedical innovations may form the core elements of advanced extravehicular space suits that have numerous advantages, such as continuous real-time health monitoring, virtually instantaneous in situ diagnostics, the auto-administration of therapeutics, and the capacities to address serious accidental circumstances and performance of emergency interventions.
The laborious, uneconomical process of sequencing DNA molecules - a technology used to identify, diagnose, and perhaps find treatments for diseases - could become much faster and cheaper thanks [...]
NanoApps Medical Inc. CEO Frank Boehm has signed with IOP Publishing to produce Nanomedical Brain/Cloud Interface: Explorations and Implications - a book that will explore the notion of a [...]
Public, permissionless blockchains and the EU’s GDPR: The coming clash between technology and the law?
From a blog by VALID advisor Christian Sillaber, Senior Researcher on IT-Security The European Union’s General Data Protection Regulation (GDPR) came into effect on May 25, 2018. It is [...]
Researchers of the Institute of Biotechnology and Biomedicine (IBB-UAB) have generated four peptides, molecules smaller than proteins, capable of self-assembling in a controlled manner to form nanomaterials. The research, [...]
About NanoApps Medical Inc
NanoApps Medical, Inc. was incorporated by Frank Boehm in 2009 with the goal of developing advanced nanomedical diagnostic and therapeutic technologies for the benefit of individuals across both the developing and developed worlds.
The larger picture will be to eventually attain a situation of “Global Health Care Equivalency” (GHCE) where any individual on the planet may have access to the same advanced, high quality, and cost effective nanomedical diagnostic and therapeutic technologies, no matter where they happen to reside, or under what conditions they live. Boehm is now compiling a book that will articulate this grand vision.
Further, NanoApps Medical is ambitiously aiming to transition terrestrial nanomedicine to space applications to facilitate future Lunar and Mars missions, such as those being boldly planned by NASA and SpaceX.